Universal Biomedics Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 31 Year, 8 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.00 Cr
- Revenue Growth -19.37%
- Profit Growth 94.47%
- Ebitda -13.56%
- Net Worth -5.84%
- Total Assets -10.23%
About Universal Biomedics
Universal Biomedics Private Limited (UBPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 May 1993 and has a history of 31 years and eight months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Daniel Peter and Ruby Daniel serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U52599TN1993PTC025078
-
Company No.
025078
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 May 1993
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Universal Biomedics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daniel Peter
|
Director | 18-May-1993 | Current |
|
Ruby Daniel
|
Director | 31-Mar-2013 | Current |
Financial Performance of Universal Biomedics.
Universal Biomedics Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 19.37% decrease. The company also saw a substantial improvement in profitability, with a 94.47% increase in profit. The company's net worth dipped by a decrease of 5.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Universal Biomedics?
In 2017, Universal Biomedics had a promoter holding of 48.33% and a public holding of 51.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- The Federal Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 1997 | The Federal Bank Limited | ₹1.00 Cr | Open |
How Many Employees Work at Universal Biomedics?
Unlock and access historical data on people associated with Universal Biomedics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Universal Biomedics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Biomedics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
